Efficacy and Safety of Cabotegravir–Rilpivirine in PLWH: A Real-World Study
CAB + RPV demonstrated high efficacy and tolerability in a real-world setting, with favorable immunological and metabolic outcomes. These findings support its use as a viable therapeutic option for PLWH, especially those with adherence barriers. Further long-term studies are warranted to confirm these results across broader populations.
Authors
- Ylenia Russotto (ORCID: https://orcid.org/0000-0001-9514-133X)
- Andrea De Vito (ORCID: https://orcid.org/0000-0002-8265-5400)
- Viviana Coco
- Emmanuele Venanzi Rullo (ORCID: https://orcid.org/0000-0001-8273-5382)
- Eugenia Pistarà
- Arturo Montineri
- Benedetto Maurizio Celesia (ORCID: https://orcid.org/0000-0002-6919-1955)
- Grazia Pantò
- Giuseppe Nunnari (ORCID: https://orcid.org/0000-0002-8113-8452)
- Alessia Mirabile
- Clorinda Cali
- F.P. Antonucci (ORCID: https://orcid.org/0000-0003-2536-1980)
- Carmelo Iacobello
- Giordano Madeddu (ORCID: https://orcid.org/0000-0001-6099-2273)
- Andrea Marıno (ORCID: https://orcid.org/0000-0002-5650-6911)
- Chiara Gullotta (ORCID: https://orcid.org/0000-0002-9201-8659)
- Sergio Lo Caputo (ORCID: https://orcid.org/0000-0002-4729-7548)
- Roberto Bruno
- Bruno Cacopardo (ORCID: https://orcid.org/0000-0002-7465-0714)
- Michele Salvatore Paternò Raddusa (ORCID: https://orcid.org/0009-0003-2452-4407)
- G. Conti (ORCID: https://orcid.org/0009-0005-9069-5823)
- Giovanni Francesco Pellicanò (ORCID: https://orcid.org/0000-0002-9640-8742)
- Antonina Franco
- Rosario Vecchio
- Serena Spampinato (ORCID: https://orcid.org/0009-0003-0149-2078)
- C. Frascà
- Nunziatina Villari
- Sonia Sofia
- Teresa Cirelli
Institutions
- University of Foggia (IT)
- University of Messina (IT)
- University of Sassari (IT)
- University of Catania (IT)
- University of Ragusa (IT)
- Ospedale Garibaldi (IT)
- Ospedale Cannizzaro (IT)
- Ospedali Riuniti Umberto I (IT)
Publication Details
- Journal
- Viruses
- Published
- 2025-10-24
- DOI
- https://doi.org/10.3390/v17111417
- Citations
- 1
- Primary Topic
- Cytomegalovirus and herpesvirus research
- Type
- article
- Field-Weighted Citation Impact
- 1.35